Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 8/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 8/20 | 0.38 |
| ▸ | CNR2 | P34972 | 5/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1733365 | 0.85 | GABRA1 (0.48) | GAAMAPTALDH1A1GABRA1GABRB2 | |
| SCHEMBL170383 | 0.85 | GABRA1 (0.48) | GAAMAPTALDH1A1GABRA1GABRB2 | |
| Hydrochloric Acid SCHEMBL28962287 | 0.83 | GABRA1 (0.47) | GAAMAPTALDH1A1GABRA1GABRB2 | |
| SCHEMBL2028628 | 0.83 | GABRA1 (0.47) | GAAMAPTALDH1A1GABRA1GABRB2 | |
| Hydrogen Sulfide SCHEMBL28231532 | 0.83 | GABRA1 (0.47) | GAAMAPTALDH1A1GABRA1GABRB2 | |
| Ammonia Solution, Strong SCHEMBL8756176 | 0.83 | GABRA1 (0.47) | GAAMAPTALDH1A1GABRA1GABRB2 | |
| SCHEMBL1734236 | 0.83 | XDH (0.52) | GAAMAPTTDP1ALDH1A1PPARG | |
| SCHEMBL1733361 | 0.83 | XDH (0.52) | GAAMAPTTDP1ALDH1A1PPARG | |
| Hydrochloric Acid SCHEMBL11352010 | 0.81 | GABRA1 (0.46) | GAAMAPTALDH1A1GABRA1GABRB2 | |
| Methylamine SCHEMBL28456206 | 0.80 | GABRA1 (0.44) | GAAMAPTGABRA1GABRB2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1989313-B | Alkylxylene sulfonates for enhanced oil recovery processes | CHEVRON ORONITE CO | 2011-06-15 | — | — | CN | disclosed |
| CN-100569889-C | Under-neutralized alkylxylene sulfonic acid compositions for enhanced oil recovery processes | CHEVRON ORONITE CO (US) | 2009-12-16 | — | — | CN | disclosed |
| EP-1778813-A4 | UNDER-NEUTRALIZED ALKYLXYLENE SULFONIC ACID COMPOSITION FOR ENHANCED OIL RECOVERY PROCESSES | CHEVRON ORONITE CO (US) | 2008-12-17 | — | — | EP | disclosed |
| EP-1781899-A4 | ALKYLXYLENE SULFONATES FOR ENHANCED OIL RECOVERY PROCESSES | CHEVRON ORONITE CO (US) | 2008-03-19 | — | — | EP | disclosed |
| CN-1989313-A | Alkylxylene sulfonates for enhanced oil recovery processes | CHEVRON ORONITE CO (US) | 2007-06-27 | — | — | CN | disclosed |
| CN-1989218-A | Under-neutralized alkylxylene sulfonic acid composition for enhanced oil recovery processes | CHEVRON ORONITE CO (US) | 2007-06-27 | — | — | CN | disclosed |
| EP-1781899-A2 | ALKYLXYLENE SULFONATES FOR ENHANCED OIL RECOVERY PROCESSES | Chevron Oronite Company LLC (US) | 2007-05-09 | — | — | EP | disclosed |
| EP-1778813-A2 | UNDER-NEUTRALIZED ALKYLXYLENE SULFONIC ACID COMPOSITION FOR ENHANCED OIL RECOVERY PROCESSES | Chevron Oronite Company LLC (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2005018300-A2 | ALKYLXYLENE SULFONATES FOR ENHANCED OIL RECOVERY PROCESSES | CHEVRON ORONITE COMPANY LLC (US) | 2005-03-03 | — | — | WO | disclosed |
| WO-2004101473-A2 | UNDER-NEUTRALIZED ALKYLXYLENE SULFONIC ACID COMPOSITION FOR ENHANCED OIL RECOVERY PROCESSES | CHEVRON ORONITE COMPANY LLC (US) | 2004-11-25 | — | — | WO | disclosed |